Business

Apollo Hospitals to Acquire IFC’s Stake in Retail Healthcare Arm for Rs 1,254 Crore

The transaction involves acquiring over 41 crore shares held jointly by IFC Washington and IFC EAF Apollo Investment Company in Apollo Health and Lifestyle Ltd. (AHLL) at a floor price of Rs 301.09 per share.

• By Newsdesk
• New Delhi
• Sep 13, 2025

Business

Apollo Hospitals has announced plans to purchase the International Finance Corporation’s (IFC) entire stake in its retail healthcare subsidiary for ₹1,254 crore in cash.

The transaction involves acquiring over 41 crore shares held jointly by IFC Washington and IFC EAF Apollo Investment Company in Apollo Health and Lifestyle Ltd. (AHLL) at a floor price of ₹301.09 per share.

Following regulatory approval from the Competition Commission of India, AHLL will become a wholly owned subsidiary of Apollo Hospitals, with Apollo holding around 99.42 percent of shares; the remaining 0.58 percent will be reserved for an employee stock option pool.

Founded in 2000, AHLL operates “Apollo Clinics” across India and the Middle East, offering services such as multispecialty care, diagnostics, maternal and child health, diabetes management, and centres for elective surgery. In the fiscal year 2024–25, its turnover rose to ₹1,553 crore from ₹1,365 crore the previous year.

Apollo Hospitals stated that the buyout would strengthen AHLL’s ability to focus on its core verticals, accelerate innovation, and make personalised care models more accessible.

Separately, Apollo has unveiled plans for a new 100-bed oncology centre in Gurugram, to be developed under Phase 2 of its upcoming 500-bed hospital. With an investment of ₹573 crore, the centre will feature proton therapy and forms part of Apollo’s goal to double its oncology business to over ₹5,000 crore within the next three to four years.